BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12096833)

  • 1. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
    J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
    J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo.
    Lacey DL; Tan HL; Lu J; Kaufman S; Van G; Qiu W; Rattan A; Scully S; Fletcher F; Juan T; Kelley M; Burgess TL; Boyle WJ; Polverino AJ
    Am J Pathol; 2000 Aug; 157(2):435-48. PubMed ID: 10934148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
    Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
    Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N; Udagawa N; Suda T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IGF-I signaling in regulating osteoclastogenesis.
    Wang Y; Nishida S; Elalieh HZ; Long RK; Halloran BP; Bikle DD
    J Bone Miner Res; 2006 Sep; 21(9):1350-8. PubMed ID: 16939393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
    Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Mochizuki S; Tomoyasu A; Yano K; Goto M; Murakami A; Tsuda E; Morinaga T; Higashio K; Udagawa N; Takahashi N; Suda T
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3597-602. PubMed ID: 9520411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.
    Shevde NK; Bendixen AC; Dienger KM; Pike JW
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7829-34. PubMed ID: 10869427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.
    Abu-Amer Y
    J Clin Invest; 2001 Jun; 107(11):1375-85. PubMed ID: 11390419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
    Okada Y; Lorenzo JA; Freeman AM; Tomita M; Morham SG; Raisz LG; Pilbeam CC
    J Clin Invest; 2000 Mar; 105(6):823-32. PubMed ID: 10727451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel molecular mechanism modulating osteoclast differentiation and function.
    Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K
    Bone; 1999 Jul; 25(1):109-13. PubMed ID: 10423033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production.
    Takami M; Woo JT; Nagai K
    Cell Tissue Res; 1999 Nov; 298(2):327-34. PubMed ID: 10571121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.
    Arai F; Miyamoto T; Ohneda O; Inada T; Sudo T; Brasel K; Miyata T; Anderson DM; Suda T
    J Exp Med; 1999 Dec; 190(12):1741-54. PubMed ID: 10601350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells.
    Jimi E; Ikebe T; Takahashi N; Hirata M; Suda T; Koga T
    J Biol Chem; 1996 Mar; 271(9):4605-8. PubMed ID: 8617720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
    Itonaga I; Sabokbar A; Murray DW; Athanasou NA
    Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.